Navigation Links
Pancreatic Cancer Advocates Call on Congress to Protect Medical Research Funding From Sequestration Cuts
Date:6/17/2013

MANHATTAN BEACH, Calif., June 17, 2013 /PRNewswire/ -- Over 550 people from across the country, including nearly 100 pancreatic cancer survivors, will participate in the Seventh Annual Pancreatic Cancer Advocacy Day on June 18, 2013 to thank Congress for passing the Recalcitrant Cancer Research Act and tell them that their fight isn't over. Advocates from the Pancreatic Cancer Action Network will call on Congress to support a permanent fix to sequestration and provide sustained adequate funding for the National Institutes of Health (NIH) and the National Cancer Institute (NCI). 

(Logo:  http://photos.prnewswire.com/prnh/20111004/LA79914LOGO)

"We are extremely grateful to Congress for passing the Recalcitrant Cancer Research Act and to President Obama for signing the bill into law, but our work is far from over. Unfortunately, due to the sequestration cuts to NCI and NIH, the progress made possible by passing this bill is currently in jeopardy," said Julie Fleshman, president and CEO of the Pancreatic Cancer Action Network.  "Continued strong support of federal funding for medical research is not only critical to curing diseases like pancreatic cancer, but is also important for the continued growth of our economy.  On Advocacy Day, we will tell Congress to issue a cease and desist order on the cuts to our nation's medical research enterprise so that we can get back to the business of saving lives."

The five year survival rate for pancreatic cancer is just six percent – the lowest of all major cancers. This statistic is particularly alarming when you consider the survival rate for all cancers is 68 percent. Pancreatic cancer is currently the fourth leading cause of cancer death in the United States, but is anticipated to become the second by 2020. Fed
'/>"/>

SOURCE Pancreatic Cancer Action Network
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AXIOS™ Stent and Delivery System Study Demonstrates Successful Treatment of Pancreatic Pseudocysts and Acute Cholecystitis
2. Trovagene to Study Trans-Renal KRAS Mutation Detection in Pancreatic Cancer
3. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
4. Scottsdale Healthcare, TGen study shows Abraxane/gemcitabine combination extends survival of pancreatic cancer patients
5. Targovax AS Announces First Patient Included in Phase I/II Clinical Study With the Therapeutic Cancer Vaccine TG01 in Operable Pancreatic Cancer
6. Pancreatic Cancer Action Network Opposes Sequestration Cuts To National Institutes Of Health & Cancer Research Grants
7. The Market for Pancreatic Cancer Therapies Will Nearly Double to $1.3 Billion in 2022, Fueled by the Entry of Three Novel Agents
8. Researchers Funded By The Pancreatic Cancer Action Network Leverage $9.15 Million Investment By The Organization Into $91 Million In Subsequent Pancreatic Cancer Research Funding
9. Metabolic Solutions Development Company announces publication of data describing potential for new drugs to maintain pancreatic beta-cells in treating diabetes
10. Halozymes Phase 1b Clinical Trial Of PEGPH20 With Gemcitabine Indicates Positive Activity Against Pancreatic Cancer
11. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015 Amgen (NASDAQ: AMGN ... Phase 3, global, randomized, placebo-controlled trials evaluating AMG ... secondary hyperparathyroidism (SHPT) in patients with chronic kidney ... primary endpoint, demonstrating that a greater proportion of ... greater than 30 percent reduction in parathyroid hormone ...
(Date:5/28/2015)... 28, 2015 Zimmer Holdings, Inc. (NYSE and ... agreements with buyers to divest in the ... System assets, Biomet Discovery® Elbow System assets and Cobalt™ ... of Zimmer,s pending acquisition of Biomet, Inc. ("Biomet").  ... work constructively with the Bureau of Competition Staff of ...
(Date:5/28/2015)... , May 28, 2015  Maetrics ( http://maetrics.com ), ... sciences sector, wrapped up a successful conference, "The cost ... Technology industry," today in Zurich . ... ) and its Switzerland -based team, ... the Medical Technology field to an exclusive local audience. ...
Breaking Medicine Technology:Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2
... 23, 2012  Edgemont Pharmaceuticals, LLC, a neuroscience focused ... now available by prescription nationwide. This is the ... single-dose tablet. The U.S. Food and Drug Administration ... its fluoxetine tablets in October 2011. ...
... Israel, Jan. 23, 2012 InspireMD, Inc. (OTC BB: ... focusing on the development and commercialization of its proprietary ... Myocardial Infarctions, today announced its business objectives for 2012 ... based on the Company,s proprietary MicroNet™ platform technology. ...
Cached Medicine Technology:Edgemont - New Fluoxetine Tablets, 60 mg Now Available 2Edgemont - New Fluoxetine Tablets, 60 mg Now Available 3Edgemont - New Fluoxetine Tablets, 60 mg Now Available 4Edgemont - New Fluoxetine Tablets, 60 mg Now Available 5Edgemont - New Fluoxetine Tablets, 60 mg Now Available 6InspireMD Provides Corporate Update, Plans for 2012 2InspireMD Provides Corporate Update, Plans for 2012 3InspireMD Provides Corporate Update, Plans for 2012 4InspireMD Provides Corporate Update, Plans for 2012 5InspireMD Provides Corporate Update, Plans for 2012 6
(Date:5/30/2015)... May 30, 2015 Promising clinical trial ... (ASCO) Annual Meeting 2015 show activity of the investigational ... case specifically against brain metastases and in another case ... patients. , "I am thrilled to have been able ... early 40s. She didn't have any other great treatment ...
(Date:5/30/2015)... The results of a 40+ year ... high potential to cause mesothelioma, regardless of the volume ... on the Surviving Mesothelioma website. , The study ... Lodz, Poland found that, among the 138 cases of ... 2012, all of them happened at plants that had, ...
(Date:5/30/2015)... New York (PRWEB) May 30, 2015 ... pay $100 million in punitive and compensatory damages ... plaintiff who suffered serious complications following implantation of ... to a verdict rendered on May 28th in ... million in compensatory damages after the jury found ...
(Date:5/30/2015)... of Industry, CA (PRWEB) May 30, 2015 ... best-in-class technology and foreign travelers who experienced OGAWA products ... available in the U.S. , A leader in ... OGAWA is a cutting-edge designer, researcher, developer and manufacturer ... the longevity and superior craftsmanship of their products, health ...
(Date:5/30/2015)... CA (PRWEB) May 30, 2015 The ... Services in coordination with ONEgeneration Senior Enrichment Center, headed ... Manager Raymond de Guzman and Brain Fitness Program Director ... joined this event learned that there are many ways ... Tee Bar showed the residents the different ways to ...
Breaking Medicine News(10 mins):Health News:ONT-380 has Stage IV HER2+ Breast Cancer Patient 'Worrying About Normal Stuff Again' 2Health News:ONT-380 has Stage IV HER2+ Breast Cancer Patient 'Worrying About Normal Stuff Again' 3Health News:New Study Finds Close Link Between Crocidolite Asbestos and Deadly Mesothelioma, According to Surviving Mesothelioma 2Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 2Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 3Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 4Health News:Award-winning OGAWA Massage Chairs Finally Available for purchase in North America. 2Health News:Award-winning OGAWA Massage Chairs Finally Available for purchase in North America. 3Health News:1Heart Caregiver Services Brings Brain Fitness Education Seminar at ONEgeneration 2Health News:1Heart Caregiver Services Brings Brain Fitness Education Seminar at ONEgeneration 3
... Nov. 4 (HealthDay News) -- Many smokers in the United ... as snuff and chew tobacco, a combination that makes quitting ... analyzed data from the 2009 Behavioral Risk Factor Surveillance System ... smokeless tobacco ranged from 0.9 percent in Puerto Rico to ...
... A patient with a long head biceps (LHB) tendinopathy, ... may also have a shoulder problem and/or a rotator ... trauma, overuse, inflammation or degeneration. Because of the ... severity, a patient needs a thorough examination, including radiographic ...
... THURSDAY, Nov. 4 (HealthDay News) -- Babies are born ... including one linked to introspection, a new study shows. ... development and activity. Scientists at the MRC Clinical ... to examine the brains of 70 babies born at ...
... 3 (HealthDay News) -- Friendly discussions with other people can ... competitive in tone aren,t helpful, finds a new study. ... way you do when you,re making friends, can provide mental ... the Institute for Social Research at the University of Michigan, ...
... less healthy than their English counterparts, but they live as long ... study by researchers from the RAND Corporation and the Institute for ... 55 to 64 have higher rates of chronic diseases than ... And Americans age 65 and older -- while still sicker than ...
... Edith P. Mitchell, M.D., clinical professor, Department of ... Jefferson University, and associate director of Diversity Programs ... recently named ,Physician of the Year, by CancerCare, ... support services to anyone affected by cancer: people ...
Cached Medicine News:Health News:Smokeless Tobacco Use Widespread in Some States 2Health News:Brain May Be More Developed at Birth Than Thought 2Health News:Good Conversation Can Boost Brain Power, Study Finds 2Health News:Americans less healthy than English, but live as long or longer, study finds 2Health News:Americans less healthy than English, but live as long or longer, study finds 3Health News:CancerCare names Jefferson professor Physician of the Year 2
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
... The ADVIA 1650 has minimal requirements for ... reagent consumption (as low as 80 L/test) ... maximizing management efficiency. , , Outstanding productivity ... throughput of up to 1650 tests/hour provide ...
... Every day you face key challenges. Reducing ... more complex laboratory workload. Meeting ever-increasing expectations ... laboratory quality while dealing with labor shortages. ... of patient care. Now theres targeted relief ...
... Roche Diagnostics Task Targeted Automation ... state-of-the-art automation of pre- and ... decapping, sorting / archiving of ... bar code labeled secondary tubes. ...
Medicine Products: